Stathmin Is Dispensable for Tumor Onset in Mice

• Sara D’Andrea,

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Stefania Berton,

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Ilenia Segatto,

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Linda Fabris,

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Vincenzo Canzonieri,

  Affiliation Pathology Unit, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Alfonso Colombatti,

  Affiliations Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy, Dipartimento di Scienze e Tecnologie Biomediche and MATI Center of Excellence, University of Udine, Udine, Italy

  ⨯
• Andrea Vecchione,

  Affiliation Division of Pathology, II University of Rome “La Sapienza”, Ospedale Santo Andrea, Rome, Italy

  ⨯
• Barbara Belletti ,

  * E-mail: bbelletti@cro.it (BB); gbaldassarre@cro.it (GB)

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯
• Gustavo Baldassarre

  * E-mail: bbelletti@cro.it (BB); gbaldassarre@cro.it (GB)

  Affiliation Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy

  ⨯